Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXON vs GSK✓SelectedUSD · GSKAXON vs GSK performance historyLatest closeAs of-2.56%11/17
Stock and ETF performance explorer

AXON vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+967.9%
GSK return
+104.0%
Excess return
+864.0%
Maximum drawdown
-65.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.6%-2.3%-0.2%-2.1%
7D-1.3%-3.0%+1.7%-0.8%
30D-23.5%+0.4%-23.8%-23.6%
3M-50.6%-1.2%-49.4%-50.5%
6M-23.8%+0.9%-24.7%-24.1%
YTD-47.4%+4.0%-51.4%-48.3%
1Y-45.0%+7.3%-52.3%-46.3%
3Y+33.6%+57.1%-23.5%+16.1%
5Y+72.7%+43.0%+29.8%+52.4%
10Y+967.9%+103.1%+864.9%+795.5%
All+967.9%+104.0%+864.0%+795.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling